Phase II study of 5-fluorouracil and leucovorin in recurrent primary brain tumor

被引：0
|
作者：
Cascino, TL
Veeder, MH
Buckner, JC
OFallon, JR
Wiesenfeld, M
Levitt, R
Goldberg, RM
Kuross, SA
Morton, RF
Scheithauer, BW
机构：
[1] ILLINOIS ONCOL RES ASSOC,COMMUNITY CLIN ONCOL PROGRAM,PEORIA,IL 61602
[2] CEDAR RAPIDS ONCOL PROJECT,CCOP,CEDAR RAPIDS,IA 52403
[3] MERITCARE HOSP,CCOP,FARGO,ND 58123
[4] GEISINGER CLIN ONCOL PROGRAM,DANVILLE,PA 17822
[5] DULUTH COMMUNITY CLIN ONCOL PROGRAM,DULUTH,MN 55805
[6] IOWA ONCOL RES ASSOC,CCOP,DES MOINES,IA 50314
来源：
JOURNAL OF NEURO-ONCOLOGY | 1996年 / 30卷 / 03期
关键词：
recurrent glioma; 5-fluorouracil; leucovorin; radiation therapy; astrocytoma; oligodendroglioma;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Thirty patients with recurrent primary brain tumors were treated with a combination of 5-fluorouracil and leucovorin. There were three responses seen. Toxicity consisted of stomatitis, diarrhea, and hematological suppression. 5-fluorouracil and leucovorin would appear to be minimally effective in recurrent brain tumors.
引用
收藏
页码：243 / 246
页数：4
相关论文
共 50 条
  • [1] 5-FLUOROURACIL DOSE INTENSITY INCREASE IN 5-FLUOROURACIL AND LEUCOVORIN COMBINATION - RESULTS OF A PHASE II STUDY
    CASCINU, S
    FEDELI, A
    FEDELI, SL
    CATALANO, G
    JOURNAL OF CHEMOTHERAPY, 1991, 3 (01) : 51 - 54
  • [2] A phase I study of 5-fluorouracil, leucovorin and levamisole
    Cleary, JF
    Arzoomanian, R
    Alberti, D
    Feierabend, C
    Storer, B
    Witt, P
    Carbone, P
    Wilding, G
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 39 (04) : 300 - 306
  • [3] Phase II study of gemcitabine, 5-fluorouracil, and leucovorin in patients with pancreatic cancer
    Marantz, A
    Jovtis, S
    Almira, E
    Balbiani, L
    Castilla, JL
    Fein, L
    Lewi, D
    Pasccon, G
    Pinckevicius, R
    Uranga, G
    Abal, M
    Muiño, M
    Reale, M
    Agusto, S
    Lastiri, F
    SEMINARS IN ONCOLOGY, 2001, 28 (03) : 44 - 49
  • [4] Leucovorin, 5-fluorouracil, and gemcitabine: A phase I study
    Poplin, E
    Roberts, J
    Tombs, M
    Grant, S
    Rubin, E
    INVESTIGATIONAL NEW DRUGS, 1999, 17 (01) : 57 - 62
  • [5] A phase I study of 5-fluorouracil, leucovorin and levamisole
    J. F. Cleary
    Rhoda Arzoomanian
    Donna Alberti
    Chris Feierabend
    Barry Storer
    Pauline Witt
    P. P. Carbone
    George Wilding
    Cancer Chemotherapy and Pharmacology, 1997, 39 : 300 - 306
  • [6] Leucovorin, 5-fluorouracil, and gemcitabine: A phase I study
    Elizabeth Poplin
    John Roberts
    Marybeth Tombs
    Steven Grant
    Eric Rubin
    Investigational New Drugs, 1999, 17 : 57 - 61
  • [7] A phase II study of ifosfamide, 5-fluorouracil and leucovorin in patients with recurrent nasopharyngeal carcinoma previously treated with platinum chemotherapy
    Chua, DTT
    Kwong, DLW
    Sham, JST
    Au, GKH
    Choy, D
    EUROPEAN JOURNAL OF CANCER, 2000, 36 (06) : 736 - 741
  • [8] A phase II study of 5-fluorouracil, leucovorin and cisplatin (FLP) for metastatic gastric cancer
    Ychou, M
    Astre, C
    Rouanet, P
    Fabre, JM
    SaintAubert, B
    Domergue, J
    Ribard, D
    Ciurana, AJ
    Janbon, C
    Pujol, H
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (11) : 1933 - 1937
  • [9] A PHASE-II STUDY OF 5-FLUOROURACIL AND LEUCOVORIN IN ADVANCED-CARCINOMA OF THE ESOPHAGUS
    ALBERTS, AS
    SCHOEMAN, L
    BURGER, W
    GREEF, F
    FALKSON, G
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1992, 15 (01): : 35 - 36
  • [10] A PHASE-II TRIAL OF IFOSFAMIDE, 5-FLUOROURACIL, AND LEUCOVORIN IN RECURRENT UTERINE CERVICAL-CANCER
    STORNES, I
    MEJLHOLM, I
    JAKOBSEN, A
    GYNECOLOGIC ONCOLOGY, 1994, 55 (01) : 123 - 125
12345